DarioHealth Corp.
DRIO Healthcare Health Information Services
DarioHealth Corp.’s revenue for fiscal 2025 (year ended December 2025) was $22.4 million, down 17.3% from fiscal 2024. In the quarter to June 2026, revenue fell 3.58%, EPS grew 76.4%, free cash flow was flat and total debt rose 1.85%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow DRIO
DarioHealth Corp. (DRIO) Altman Z-score
DarioHealth Corp.'s Altman Z-score for fiscal 2025 is −5.72, in the distress zone (below 1.81).
Altman Z-score, annual
Embed this chart
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2025 | −5.72 | (0.48) |
| FY2024 | −5.24 | 0.35 |
| FY2023 | −5.59 | (2.90) |
| FY2022 | −2.68 | (6.15) |
| FY2021 | 3.47 | 3.74 |
| FY2020 | −0.27 | 5.64 |
| FY2019 | −5.91 | 5.80 |
| FY2018 | −11.71 | 7.99 |
| FY2017 | −19.70 | 8.86 |
| FY2016 | −28.56 | (14.55) |
How fiscal 2025’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | 0.23 | — | 0.28 | |
| Retained earnings / total assets | (4.11) | — | −5.75 | |
| EBIT / total assets | (0.33) | — | −1.10 | |
| Market value of equity / total liabilities | 1.08 | — | 0.65 | |
| Sales / total assets | 0.20 | — | 0.20 | |
| Altman Z-score | Distress zone | −5.72 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Distress zone | −12.40 | ||
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| OPRX OptimizeRx Corp. compare | 3.3× |
| CCLD CareCloud, Inc. compare | 3.3× |
| LFMD LifeMD, Inc. compare | 0.0× |
| DH Definitive Healthcare Corp. compare | −1.5× |
| HCAT Health Catalyst, Inc. compare | −3.7× |
| DRIO DarioHealth Corp. | −5.7× |
| RNLXY Renalytix plc - Sponsored ADR compare | −15.6× |
| ONMD OneMedNet Corporation compare | −77.9× |
| BEAT HeartBeam, Inc. compare | — |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets